Peers: TNGX CGON KYMR BMRN CRNX RYTM APGE INCY KRYS AXSM

| Held by: VTI XBI IWM VXF IBB VTWO IWO SCHA FYC DWAS

Index	RUT
Market Cap	1.33B
Enterprise Value	1.38B
Income	-138.18M
Sales	0.00M
Book/sh	-3.60
Cash/sh	9.06
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	110
IPO	May 29, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	9.98
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.07
Current Ratio	5.07
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-8.88
EPS next Y	-8.94
EPS next Q	-2.45
EPS this Y	-5.27%
EPS next Y	6.09%
EPS next 5Y	15.68%
EPS past 3/5Y	3.40% -
Sales past 3/5Y	-15.98% -
EPS Y/Y TTM	19.23%
Sales Y/Y TTM	-100.00%
EPS Q/Q	-26.26%
Sales Q/Q	-100.00%
Earnings	Aug 13 AMC
EPS/Sales Surpr.	-2.63% -

Insider Own	25.48%
Insider Trans	1.63%
Inst Own	87.96%
Inst Trans	19.39%
ROA	-75.44%
ROE	-1773.60%
ROIC	-109.53%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-7.59%
SMA50	-12.78%
SMA200	-1.19%
Trades

Shs Outstand	14.71M
Shs Float	10.97M
Short Float	31.29%
Short Ratio	12.34
Short Interest	3.43M
52W High	155.29 -41.79%
52W Low	28.16 220.98%
Volatility	5.17% 5.61%
ATR (14)	5.88
RSI (14)	39.33
Beta	3.86
Rel Volume	0.06
Avg Volume	278.17K
Volume	845

Perf Week	-2.56%
Perf Month	-11.18%
Perf Quarter	3.43%
Perf Half Y	8.76%
Perf YTD	14.41%
Perf Year	151.50%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.50
Target Price	266.67
Prev Close	85.26
Price	90.39
Change %	6.01%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-24-26	Initiated	H.C. Wainwright	Buy	$245
Apr-08-26	Initiated	Stifel	Buy	$150
Jul-23-24	Initiated	JMP Securities	Mkt Perform

Oct-13-26 04:00PM	Inhibrx Announces Participation in Upcoming Scientific Conferences (PR Newswire)
Sep-08-26 08:51AM	Inhibrx Shares Rise After Positive Phase 2 Head and Neck Cancer Data (InvestorsHub) -5.64%
07:30AM	Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study (PR Newswire)
Sep-04-26 04:00PM	Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study (PR Newswire)
Aug-13-26 04:04PM	Inhibrx Reports Second Quarter 2026 Financial Results (PR Newswire) -8.91%
09:00AM	Loading…
Jul-16-26 09:00AM	Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million (PR Newswire)
Jun-15-26 09:15AM	Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma (PR Newswire)
May-14-26 04:02PM	Inhibrx Reports First Quarter 2026 Financial Results (PR Newswire) -6.47%
May-11-26 08:26AM	This Surging Biotech Stock Shrugs Off Positive Cancer Trial Results and Slips. What to Know. (Barrons.com) -5.04%
08:00AM	Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefit Over PD-1 Monotherapy (PR Newswire)
06:00AM	Inhibrx delivers differentiated cancer drug data; Fractyl starts diabetes gene therapy trial (BioPharma Dive)
May-08-26 04:00PM	Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC (PR Newswire) +7.89%
Apr-21-26 04:05PM	Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer (PR Newswire) +36.88%
Apr-20-26 05:03PM	Inhibrx To Host Webcast Presentation to Provide Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer (PR Newswire) -6.62%
Apr-08-26 09:42AM	Coinbase downgraded, Deere upgraded: Wall Street's top analyst calls (The Fly) +7.67%
04:00PM	Loading…
Mar-19-26 04:00PM	Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results (PR Newswire) -5.56% -6.09%
Mar-02-26 04:00PM	Inhibrx Announces Participation in Upcoming Scientific Conference (PR Newswire)
Dec-28-25 10:05AM	Inhibrx Advances Key Oncology Programs Toward Multiple 2026 Data Readouts (Insider Monkey)
Dec-16-25 05:00PM	Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program (PR Newswire) +7.03%
Nov-14-25 06:00AM	Inhibrx Reports Third Quarter 2025 Financial Results (PR Newswire) +6.04%
Nov-04-25 04:01PM	Inhibrx Announces Participation in Upcoming Scientific Conferences (PR Newswire)
Oct-24-25 07:40AM	Inhibrx Biosciences stock soars on chondrosarcoma Phase II victory (Clinical Trials Arena) +102.01%
Oct-23-25 04:05PM	Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts (PR Newswire) -10.03%
Oct-22-25 04:01PM	Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts (PR Newswire) -15.99%
Aug-13-25 04:05PM	Inhibrx Reports Second Quarter 2025 Financial Results (PR Newswire) +7.53%
Jul-28-25 11:11AM	Inhibrx Biosciences Advances HexAgon-HN Study for Head, Neck Cancer (Insider Monkey) +6.46%
Jul-17-25 02:05PM	Ligand Pharmaceuticals Stock Earns 84 RS Rating (Investor's Business Daily)
Jul-15-25 01:08PM	Liquidia Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
Jul-10-25 02:24PM	Arcutis Biotherapeutics Stock Scores RS Rating Upgrade (Investor's Business Daily)
May-14-25 04:05PM	Inhibrx Reports First Quarter 2025 Financial Results (PR Newswire) +10.89%
04:05PM	Loading…
Apr-01-25 04:05PM	Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President (PR Newswire)
Mar-17-25 04:05PM	Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results (PR Newswire)
Jan-21-25 05:01PM	Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer (PR Newswire) +5.19%
Jan-13-25 04:15PM	Inhibrx Biosciences Announces Loan Agreement with Oxford Finance (PR Newswire) -6.60%
Nov-14-24 04:24PM	Inhibrx Biosciences Reports Third Quarter 2024 Financial Results (PR Newswire) -7.25%
Nov-04-24 04:00PM	Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation (PR Newswire)
Sep-13-24 01:55AM	Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX) (GuruFocus.com) +8.82%
Aug-13-24 06:54PM	Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights (PR Newswire)
May-24-24 04:00PM	Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi (PR Newswire)
May-10-24 06:36PM	Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off (PR Newswire)

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

FounderMr. Mark Paul Lappe

PresidentMr. David J. Matly M.B.A.

CPAMs. Kelly Devine Deck B.S.

Vice President of OperationsMs. Bonne Adams M.B.A.

M.B.A.Ms. Kate Burke CPA

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lappe Mark	Chief Executive Officer	Oct 14 '26	Buy	84.56	10,040	848,977	745,588	Oct 14 06:58 PM
Lappe Mark	Chief Executive Officer	Sep 25 '26	Buy	99.16	5,500	545,357	736,048	Sep 28 05:47 PM
Lappe Mark	Chief Executive Officer	Sep 28 '26	Buy	100.76	4,500	453,426	740,548	Sep 28 05:47 PM
Kayyem Jon Faiz	Director	Sep 23 '26	Buy	100.00	5,000	500,000	434,360	Sep 23 04:59 PM
Kayyem Jon Faiz	Director	Sep 16 '26	Buy	100.00	5,000	500,000	429,360	Sep 17 05:46 PM
MANHARD KIMBERLY	Director	Sep 11 '26	Sale	111.78	500	55,888	8,500	Sep 15 05:52 PM
MANHARD KIMBERLY	Director	Sep 14 '26	Sale	110.26	500	55,130	8,000	Sep 15 05:52 PM
MANHARD KIMBERLY	Director	Sep 15 '26	Sale	105.05	500	52,525	7,500	Sep 15 05:52 PM
MANHARD KIMBERLY	Director	Sep 15 '26	Proposed Sale	105.05	500	52,525		Sep 15 04:02 PM
MANHARD KIMBERLY	Director	Sep 14 '26	Proposed Sale	110.26	500	55,130		Sep 14 04:57 PM
MANHARD KIMBERLY	Director	Sep 11 '26	Proposed Sale	111.78	500	55,888		Sep 11 01:15 PM
MANHARD KIMBERLY	Director	Sep 09 '26	Sale	115.80	500	57,898	9,000	Sep 10 07:06 PM
MANHARD KIMBERLY	Director	Sep 08 '26	Sale	115.14	500	57,570	9,500	Sep 10 07:06 PM
MANHARD KIMBERLY	Director	Sep 09 '26	Proposed Sale	115.80	500	57,898		Sep 09 05:15 PM
MANHARD KIMBERLY	Director	Sep 08 '26	Proposed Sale	115.14	500	57,570		Sep 08 07:59 PM
Kayyem Jon Faiz	Director	Sep 08 '26	Buy	113.52	5,000	567,580	424,360	Sep 08 05:23 PM
FORSYTH DOUGLAS	Director	Sep 08 '26	Buy	114.65	2,500	286,617	227,064	Sep 08 04:26 PM
Lappe Mark	Chief Executive Officer	Sep 08 '26	Buy	105.82	25,000	2,645,399	730,548	Sep 08 04:04 PM

Open in Screener

TDIC

Dreamland Ltd

1.77

Oct 15 • 6:18 AM ET -0.51 (-22.37%)

Communication Services Advertising Agencies Hong Kong Nano NASD

Peers: CNET KRKR YDKG CHR STFS VSME DRCT HAO TC BAOS

Index	-
Market Cap	6.17M
Enterprise Value	2.03M
Income	-9.49M
Sales	6.49M
Book/sh	2.46
Cash/sh	1.88
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	16
IPO	Jul 23, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	0.95
P/B	0.72
P/C	0.94
P/FCF	-
EV/EBITDA	-
EV/Sales	0.31
Quick Ratio	1.23
Current Ratio	1.23
Debt/Eq	3.30
LT Debt/Eq	1.78
Option/Short	No / Yes

EPS (ttm)	-32.06
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-405.42% -
Sales past 3/5Y	141.48% -
EPS Y/Y TTM	-1063.88%
Sales Y/Y TTM	10.50%
EPS Q/Q	-934.36%
Sales Q/Q	-27.68%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	43.89%
Insider Trans	164.87%
Inst Own	0.05%
Inst Trans	-18.01%
ROA	-102.97%
ROE	-1011.48%
ROIC	-468.33%
Gross Margin	1.21%
Oper. Margin	-124.23%
Profit Margin	-146.21%
SMA20	-14.12%
SMA50	-23.33%
SMA200	-88.83%
Trades

Shs Outstand	3.49M
Shs Float	1.96M
Short Float	2.81%
Short Ratio	0.05
Short Interest	0.06M
52W High	750.00 -99.76%
52W Low	1.51 17.21%
Volatility	33.97% 19.27%
ATR (14)	0.44
RSI (14)	43.95
Beta	6.13
Rel Volume	2.61
Avg Volume	1.19M
Volume	154,795

Perf Week	-2.75%
Perf Month	-9.70%
Perf Quarter	-41.39%
Perf Half Y	-89.63%
Perf YTD	-92.37%
Perf Year	-98.01%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	2.28
Price	1.77
Change %	-22.37%

Jul-01-26 01:02PM	Compromised Advisor Credentials Used in Pump-and-Dump Schemes (Wealth Management) -5.48%
May-15-26 10:30AM	BC-Most Active Stocks (Associated Press) +30.00%
May-13-26 10:30AM	BC-Most Active Stocks (Associated Press) +876.69%
May-12-26 11:13AM	AI Image Platform Partnership Expands Dreamlands Push Beyond Event Management (TDIC) (InvestorsHub) +126.92%
10:30AM	BC-Most Active Stocks (Associated Press)
05:12AM	Loading…
05:12AM	Dreamland Limited's Subsidiary Trendic International Limited and LinkFung Innovation Limited Enter Into MoU to Explore Development, Implementation, and Deployment of a Comprehensive AI-Powered Intelligent Image Library Platform (GlobeNewswire)
Apr-07-26 10:30AM	BC-Most Active Stocks (Associated Press) +45.11%
Dec-05-25 07:55AM	Dreamland Limited Secures $18 Million Equity Purchase Agreement (GlobeNewswire) +40.21%
Nov-28-25 06:16AM	Dreamland Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire) +9.82%
Jul-24-25 03:17PM	Dreamland Limited Announces Closing of Initial Public Offering (GlobeNewswire)
Jul-22-25 02:38PM	Dreamland Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Dreamland Ltd. is an event management service provider specializing in the organization, planning, promotion, and management of themed experience events. It handles a wide variety of public and private events, including trade shows, conferences, concerts, exhibitions, charity galas, brand promotions, and internal corporate events. The company was founded by Seto Wai Yue in 2016 and is headquartered in Hong Kong.

FounderMs. Wai Yue Seto

Chief Financial OfficerMr. Wai Kit Lee

Head of Design & Merchandising Department and DirectorMs. Sze Man Tse

General ManagerMr. Kai Chung Luk

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Seto Wai Yue	Chief Executive Officer	Oct 09 '26	Buy	2.00	300,000	600,000	1,369,890	Oct 14 10:57 AM
Seto Wai Yue	Chief Executive Officer	Jul 07 '26	Buy	3.75	652,000	2,445,000	749,890	Jul 13 06:05 AM

Peers: DOYU FLX GLBE HUYA ZH DIBS CARG BILI BIDU RUM

| Held by: AVDV DFEM APIE EWX DFAE PGJ DFAX DFEV DFSE AVDS

Index	-
Market Cap	179.93M
Enterprise Value	341.90M
Income	-18.89M
Sales	1.50B
Book/sh	9.22
Cash/sh	7.96
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6762
IPO	May 21, 2015

P/E	-
Forward P/E	4.11
PEG	-
P/S	0.12
P/B	0.36
P/C	0.42
P/FCF	-
EV/EBITDA	12.45
EV/Sales	0.23
Quick Ratio	1.59
Current Ratio	1.90
Debt/Eq	0.58
LT Debt/Eq	0.12
Option/Short	Yes / Yes

EPS (ttm)	-0.33
EPS next Y	0.82
EPS next Q	-
EPS this Y	124.62%
EPS next Y	76.40%
EPS next 5Y	-
EPS past 3/5Y	28.42% -
Sales past 3/5Y	3.51% 1.53%
EPS Y/Y TTM	25.34%
Sales Y/Y TTM	11.59%
EPS Q/Q	152.22%
Sales Q/Q	14.19%
Earnings	Aug 27 BMO
EPS/Sales Surpr.	- -

Insider Own	0.01%
Insider Trans	-
Inst Own	26.37%
Inst Trans	-7.48%
ROA	-1.37%
ROE	-3.55%
ROIC	-3.15%
Gross Margin	73.92%
Oper. Margin	1.55%
Profit Margin	-1.26%
SMA20	6.43%
SMA50	13.23%
SMA200	22.28%
Trades

Shs Outstand	53.71M
Shs Float	53.70M
Short Float	1.14%
Short Ratio	2.71
Short Interest	0.61M
52W High	3.82 -12.21%
52W Low	2.07 61.84%
Volatility	5.55% 5.54%
ATR (14)	0.17
RSI (14)	59.97
Beta	0.40
Rel Volume	0.00
Avg Volume	226.18K
Volume	0

Perf Week	-5.63%
Perf Month	22.71%
Perf Quarter	30.86%
Perf Half Y	25.00%
Perf YTD	25.94%
Perf Year	-3.46%
Perf 3Y	9.12%
Perf 5Y	-82.19%
Perf 10Y	-77.60%
Recom	1.38
Target Price	4.57
Prev Close	3.35
Price	3.35
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-26	Upgrade	CLSA	Hold → Outperform	$3.80
Aug-30-24	Downgrade	CLSA	Outperform → Hold
Mar-26-24	Downgrade	China Renaissance	Buy → Hold
Feb-08-24	Upgrade	Daiwa Securities	Outperform → Buy
Feb-27-23	Upgrade	CLSA	Underperform → Outperform	$4.40 → $7
Jan-30-23	Initiated	JP Morgan	Overweight
Jan-11-23	Upgrade	JP Morgan	Neutral → Overweight	$9 → $10
May-16-22	Upgrade	JP Morgan	Underweight → Neutral	$5 → $8
Mar-14-22	Downgrade	JP Morgan	Overweight → Underweight	$5
Mar-11-22	Upgrade	Credit Suisse	Underperform → Neutral	$8.30
Dec-02-21	Downgrade	CLSA	Buy → Outperform
Aug-20-21	Downgrade	Daiwa Securities	Buy → Neutral	$42 → $20
Jul-23-21	Downgrade	Credit Suisse	Outperform → Underperform
Jun-08-21	Resumed	JP Morgan	Overweight	$45
May-19-21	Upgrade	Credit Suisse	Neutral → Outperform	$41
Jan-25-21	Upgrade	CLSA	Outperform → Buy	$42
Nov-24-20	Downgrade	Credit Suisse	Outperform → Neutral
Jun-03-20	Upgrade	Credit Suisse	Neutral → Outperform	$36
Mar-31-20	Downgrade	BofA/Merrill	Buy → Neutral
Nov-22-19	Downgrade	Credit Suisse	Outperform → Neutral

Show Previous Ratings

Sep-24-26 06:00AM	Baozun Announces US$10 million Share Repurchase Program (PR Newswire)
Aug-28-26 09:38AM	Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls (The Fly)
Aug-27-26 03:01PM	Baozun Inc (BZUN) (Q2 2026) Earnings Call Highlights: Revenue Climbs 7% as AI and Brand ... (GuruFocus.com) +7.09%
08:12AM	Baozun shares rise as earnings beat forecasts and profitability improves (InvestorsHub)
06:31AM	Baozun Announces Second Quarter 2026 Unaudited Financial Results (PR Newswire)
06:00AM	Loading…
Aug-13-26 06:00AM	Baozun to Announce Second Quarter 2026 Unaudited Financial Results on August 27, 2026 (PR Newswire)
Jun-16-26 07:22PM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
May-20-26 03:01PM	Baozun Inc (BZUN) Q1 2026 Earnings Call Highlights: Revenue Surge and Profit Turnaround (GuruFocus.com)
06:00AM	Baozun Announces First Quarter 2026 Unaudited Financial Results (PR Newswire)
May-15-26 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (PR Newswire) -8.89%
May-08-26 06:00AM	Baozun to Announce First Quarter 2026 Unaudited Financial Results on May 20, 2026 (PR Newswire)
Apr-23-26 07:42AM	Baozun Releases 2025 Annual Sustainability Report (PR Newswire)
06:50AM	Baozun Files Annual Reports for Fiscal Year 2025 (PR Newswire)
06:00AM	Baozun Releases 2025 Chairman Letter (PR Newswire)
Mar-26-26 02:39PM	Gap Plans 50 China Stores After First Quarterly Breakeven (GuruFocus.com) -12.10%
03:01PM	Loading…
Mar-25-26 03:01PM	Baozun Inc (BZUN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Profitability ... (GuruFocus.com) +16.43%
06:15AM	Baozun Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results (PR Newswire)
Mar-11-26 06:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on March 25, 2026 (PR Newswire)
Nov-25-25 02:00PM	Baozun Inc (BZUN) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Focus on ... (GuruFocus.com) -5.82%
05:00AM	Baozun Announces Third Quarter 2025 Unaudited Financial Results (PR Newswire)
Nov-11-25 05:00AM	Baozun to Announce Third Quarter 2025 Unaudited Financial Results on November 25, 2025 (PR Newswire)
Sep-22-25 01:32PM	Accenture Pre-Q4 Earnings: Is the Stock a Portfolio Must-Have? (Zacks)
Aug-29-25 03:04AM	Baozun Inc (BZUN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion (GuruFocus.com) +6.27%
Aug-28-25 06:00AM	Baozun Announces Second Quarter 2025 Unaudited Financial Results (PR Newswire) +12.72%
Aug-14-25 06:00AM	Baozun to Announce Second Quarter 2025 Unaudited Financial Results on August 28, 2025 (PR Newswire)
Jul-21-25 09:40AM	Is Baozun (BZUN) Stock Outpacing Its Computer and Technology Peers This Year? (Zacks)
Jun-18-25 06:00AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
May-22-25 03:03AM	Baozun Inc (BZUN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... (GuruFocus.com)
May-21-25 06:00AM	Baozun Announces First Quarter 2025 Unaudited Financial Results (PR Newswire)
May-16-25 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (PR Newswire)
06:00AM	Loading…
May-07-25 06:00AM	Baozun to Announce First Quarter 2025 Unaudited Financial Results on May 21, 2025 (PR Newswire) +6.84%
Apr-23-25 07:17AM	Baozun Releases 2024 Sustainability Report (PR Newswire)
06:38AM	Baozun Files Annual Reports for Fiscal Year 2024 (PR Newswire)
06:00AM	Baozun Releases 2024 Chairman Letter (PR Newswire)
Apr-18-25 11:35AM	Is Baozun Inc. (BZUN) the Best Internet Retail Stock to Buy According to Analysts? (Insider Monkey)
Mar-30-25 08:00AM	Baozun: Decent Buy Opportunity After The Correction (Seeking Alpha)
Mar-21-25 03:01AM	Baozun Inc (BZUN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
Mar-20-25 12:30PM	Baozun (BZUN) Q4 2024 Earnings Call Transcript (Motley Fool) -12.71%
09:01AM	Baozun Inc. (BZUN) Q4 2024 Earnings Call Transcript (SeekingAlpha)
06:00AM	Baozun Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results (PR Newswire)
Mar-19-25 06:00PM	Here's the major earnings before the open tomorrow (SeekingAlpha)
Mar-06-25 05:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 (PR Newswire)
Feb-27-25 10:32AM	Why Baozun Inc. (BZUN) Is Skyrocketing So Far In 2025 (Insider Monkey) -5.52%
Feb-10-25 07:56PM	Why Baozun Inc. (BZUN) Is Skyrocketing (Insider Monkey)
Nov-22-24 02:02AM	Baozun Inc (BZUN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Profitability ... (GuruFocus.com)
Nov-21-24 11:00AM	Baozun (BZUN) Q3 2024 Earnings Call Transcript (Motley Fool) -8.11%
05:00AM	Baozun Announces Third Quarter 2024 Unaudited Financial Results (PR Newswire)
Nov-07-24 05:00AM	Baozun to Announce Third Quarter Financial Results of 2024 Unaudited Financial Results on November 21, 2024 (PR Newswire)
Oct-17-24 06:28AM	Baozun Inc. Announces Strategic Share Repurchase (TipRanks)
Oct-16-24 06:50AM	Baozun Inc. Announces Strategic Share Repurchase (TipRanks)
Oct-10-24 06:29AM	Baozun Announces Share Repurchase Update (TipRanks)
Oct-09-24 07:27AM	Baozun Announces Recent Share Repurchase (TipRanks)
Oct-08-24 07:17AM	Baozun Announces Recent Share Repurchase (TipRanks) -10.22%
Oct-05-24 06:31AM	Baozun Announces Share Repurchase Update (TipRanks)
Aug-28-24 02:30PM	Baozun (BZUN) Q2 2024 Earnings Call Transcript (Motley Fool)
06:28AM	Baozun Announces Second Quarter 2024 Unaudited Financial Results (PR Newswire)
Aug-14-24 06:00AM	Baozun to Announce Second Quarter and Half-Year Interim Financial Results of 2024 Unaudited Financial Results on August 28, 2024 (PR Newswire)
Jun-12-24 07:26AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
May-31-24 05:30AM	Alibaba sells stake in e-commerce branding services firm Baozun for US$21.8 million as part of corporate restructuring (South China Morning Post)
May-29-24 08:03AM	Baozun Inc. (NASDAQ:BZUN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-28-24 01:00PM	Baozun (BZUN) Q1 2024 Earnings Call Transcript (Motley Fool)
10:52AM	BZUN Stock Earnings: Baozun Beats Revenue for Q1 2024 (InvestorPlace)
06:00AM	Baozun Announces First Quarter 2024 Unaudited Financial Results (PR Newswire)
May-14-24 06:00AM	Baozun to Announce First Quarter 2024 Unaudited Financial Results on May 28, 2024 (PR Newswire)
May-10-24 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (PR Newswire)
Apr-19-24 07:13AM	Baozun Releases 2023 Sustainability Report (PR Newswire)
06:34AM	Baozun Strengthens Leadership Team (PR Newswire)
06:26AM	Baozun Files Annual Reports for Fiscal Year 2023 (PR Newswire)
06:00AM	Baozun Releases 2023 Chairman Letter (PR Newswire)
Mar-26-24 08:51AM	Baozun Inc. (NASDAQ:BZUN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-21-24 12:45PM	Baozun (BZUN) Q4 2023 Earnings Call Transcript (Motley Fool) -16.67%
10:53AM	BZUN Stock Earnings: Baozun Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
06:00AM	Baozun Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results (PR Newswire)
Mar-07-24 04:32PM	7 Under-$10 Stocks That Will Be Worth $100 (or More!) by 2026 (InvestorPlace)
05:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results on March 21, 2024 (PR Newswire)
Feb-16-24 03:15AM	20 Fastest Growing E-Commerce Companies in 2024 (Insider Monkey)
Jan-24-24 06:00AM	Baozun Announces US$20 million Share Repurchase Program (PR Newswire) +17.33%
Nov-24-23 08:44AM	Baozun Inc. (NASDAQ:BZUN) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.46%
Nov-22-23 10:45AM	Baozun (BZUN) Q3 2023 Earnings Call Transcript (Motley Fool) -10.12%
05:00AM	Baozun Announces Third Quarter 2023 Unaudited Financial Results (PR Newswire)
Nov-08-23 05:00AM	Baozun to Announce Third Quarter Financial Results of 2023 Unaudited Financial Results on November 22, 2023 (PR Newswire)
Oct-05-23 05:17PM	Ray Dalio on Potential US-China War and Rise of China (Insider Monkey) +5.72%
Aug-29-23 08:12AM	Baozun Inc. (NASDAQ:BZUN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-28-23 03:39PM	Why Baozun Stock Popped Today (Motley Fool) +12.47%
01:00PM	Baozun (BZUN) Q2 2023 Earnings Call Transcript (Motley Fool)
12:37PM	Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories (Benzinga)
06:00AM	Baozun Announces Second Quarter 2023 Unaudited Financial Results (PR Newswire)
Aug-14-23 06:00AM	Baozun to Announce Second Quarter and Half-Year Interim Financial Results of 2023 Unaudited Financial Results on August 28, 2023 (PR Newswire)
Jul-14-23 10:22AM	Positive week for Baozun Inc. (NASDAQ:BZUN) institutional investors who lost 52% over the past year (Simply Wall St.)
Jun-27-23 04:18PM	Why Alibaba, Bilibili, and Baozun Rose Today (Motley Fool)
Jun-15-23 08:20AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
Jun-02-23 11:54AM	Why Shares of Alibaba, Dingdong, and Baozun Are Rising Today (Motley Fool)
May-25-23 02:47PM	Why Baozun Stock Was Falling Today (Motley Fool) -9.65%
01:30PM	Baozun (BZUN) Q1 2023 Earnings Call Transcript (Motley Fool)
06:00AM	Baozun Announces First Quarter 2023 Unaudited Financial Results (PR Newswire)
May-15-23 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (GlobeNewswire) +7.57%
May-12-23 06:00AM	Baozun to Announce First Quarter 2023 Unaudited Financial Results on May 25, 2023 (GlobeNewswire) -5.42%
Apr-29-23 08:34AM	Baozun (NASDAQ:BZUN) investors are sitting on a loss of 90% if they invested five years ago (Simply Wall St.)
Apr-25-23 06:34AM	Baozun Releases 2022 Sustainability Report (GlobeNewswire)
06:27AM	Baozun Files Annual Report on Form 20-F for Fiscal Year 2022 (GlobeNewswire)

Baozun, Inc. is a holding company, which engages in the provision of brand electronic commerce (e-commerce) services and solutions. Its services include apparel and accessories, appliances, electronics, home and furnishings, food and health products, beauty and cosmetics, fast moving consumer goods, and mother and baby products, and insurance and automobiles. The firm operates through the E-Commerce and Brand Management segments. The company was founded by Wen Bin Qiu, Jun Hua Wu, and Qing Yu Zhang in August 2007 and is headquartered in Shanghai, China.

Co-FounderMr. Wenbin Qiu

Co-FounderMr. Junhua Wu

Chief Financial OfficerMs. Yanjie Zhu

Joint Company Secretary and Senior Director of Corporate Development & Investor RelationsMs. Wendy Shu Sun

Senior Vice PresidentMr. Yuen Lung Kwok

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Qiu Wenbin	Chief Executive Officer	Oct 13 '26	Buy	3.47	5,800	20,126	1,678,572	Oct 14 06:20 AM
Qiu Wenbin	Chief Executive Officer	Oct 12 '26	Buy	3.34	6,000	20,040	1,672,772	Oct 14 06:20 AM
Qiu Wenbin	Chief Executive Officer	Sep 18 '26	Buy	2.88	7,000	20,160	1,659,872	Sep 22 06:21 AM
Qiu Wenbin	Chief Executive Officer	Sep 21 '26	Buy	2.85	6,900	19,665	1,666,772	Sep 22 06:21 AM
Qiu Wenbin	Chief Executive Officer	Sep 17 '26	Buy	2.84	7,100	20,164	1,652,872	Sep 18 06:48 AM
Qiu Wenbin	Chief Executive Officer	Sep 16 '26	Buy	2.74	7,300	20,002	1,645,772	Sep 18 06:48 AM
Wu Junhua	Chief Strategy Officer	Sep 15 '26	Buy	2.73	13,900	37,947	281,170	Sep 17 06:09 AM
Qiu Wenbin	Chief Executive Officer	Sep 14 '26	Buy	2.74	7,300	20,002	1,631,172	Sep 16 06:14 AM
Qiu Wenbin	Chief Executive Officer	Sep 15 '26	Buy	2.72	7,300	19,856	1,638,472	Sep 16 06:14 AM
Wu Junhua	Chief Strategy Officer	Sep 02 '26	Buy	2.85	13,500	38,475	267,270	Sep 04 06:08 AM
Yu Bin Helen	Director	Aug 28 '26	Option Exercise	0.00	5,603	0	17,269	Sep 01 06:26 AM
Ye Changqing	Director	Jun 30 '26	Option Exercise	0.00	17,269	0	17,269	Jul 02 06:22 AM
Wu Junhua	Chief Strategy Officer	Jun 24 '26	Buy	2.85	29,000	82,650	253,770	Jun 26 07:39 AM
Qiu Wenbin	Chief Executive Officer	Jun 22 '26	Buy	2.81	10,000	28,100	1,623,872	Jun 24 07:24 AM
Qiu Wenbin	Chief Executive Officer	Jun 17 '26	Buy	2.83	10,000	28,300	1,603,872	Jun 22 06:33 AM
Qiu Wenbin	Chief Executive Officer	Jun 18 '26	Buy	2.77	10,000	27,700	1,613,872	Jun 22 06:33 AM
Wu Junhua	Chief Strategy Officer	Jun 17 '26	Buy	2.84	18,500	52,540	224,770	Jun 22 06:27 AM
Qiu Wenbin	Chief Executive Officer	Jun 15 '26	Buy	2.79	10,000	27,900	1,583,872	Jun 17 07:49 AM
Qiu Wenbin	Chief Executive Officer	Jun 16 '26	Buy	2.72	10,000	27,200	1,593,872	Jun 17 07:49 AM
Qiu Wenbin	Chief Executive Officer	Jun 12 '26	Buy	2.72	10,000	27,200	1,573,872	Jun 15 06:21 AM
Qiu Wenbin	Chief Executive Officer	Jun 11 '26	Buy	2.67	10,000	26,700	1,563,872	Jun 15 06:21 AM
Wu Junhua	Chief Strategy Officer	Jun 11 '26	Buy	2.69	18,000	48,420	206,270	Jun 15 06:19 AM
Qiu Wenbin	Chief Executive Officer	Jun 09 '26	Buy	2.72	10,000	27,200	1,543,872	Jun 11 06:15 AM
Qiu Wenbin	Chief Executive Officer	Jun 10 '26	Buy	2.64	10,000	26,400	1,553,872	Jun 11 06:15 AM
Qiu Wenbin	Chief Executive Officer	Jun 08 '26	Buy	2.77	10,000	27,700	1,533,872	Jun 09 06:20 AM
Qiu Wenbin	Chief Executive Officer	Jun 05 '26	Buy	2.65	10,000	26,500	1,523,872	Jun 09 06:20 AM
Qiu Wenbin	Chief Executive Officer	Jun 04 '26	Buy	2.67	10,000	26,700	1,513,872	Jun 05 06:16 AM
Qiu Wenbin	Chief Executive Officer	Jun 03 '26	Buy	2.63	10,000	26,300	1,503,872	Jun 05 06:16 AM
Wu Junhua	Chief Strategy Officer	Jun 01 '26	Buy	2.70	20,000	54,000	188,270	Jun 03 06:30 AM
Qiu Wenbin	Chief Executive Officer	Jun 01 '26	Buy	2.73	10,000	27,300	1,483,872	Jun 03 06:26 AM
Qiu Wenbin	Chief Executive Officer	Jun 02 '26	Buy	2.69	10,000	26,900	1,493,872	Jun 03 06:26 AM
Wu Junhua	Chief Strategy Officer	May 28 '26	Buy	2.56	19,500	49,920	168,270	Jun 01 07:53 AM
Qiu Wenbin	Chief Executive Officer	May 29 '26	Buy	2.57	10,000	25,700	1,473,872	Jun 01 07:46 AM
Qiu Wenbin	Chief Executive Officer	May 28 '26	Buy	2.56	10,000	25,600	1,463,872	Jun 01 07:46 AM
Qiu Wenbin	Chief Executive Officer	May 27 '26	Buy	2.58	10,000	25,800	1,453,872	May 28 06:48 AM
Qiu Wenbin	Chief Executive Officer	May 26 '26	Buy	2.55	10,000	25,500	1,443,872	May 28 06:48 AM
Wu Junhua	Chief Strategy Officer	May 26 '26	Buy	2.55	10,000	25,500	148,770	May 28 06:45 AM
Qiu Wenbin	Chief Executive Officer	Apr 17 '26	Buy	3.14	16,000	50,240	1,433,872	Apr 21 06:15 AM
Qiu Wenbin	Chief Executive Officer	Apr 16 '26	Buy	2.84	17,500	49,700	1,417,872	Apr 17 07:33 AM
Qiu Wenbin	Chief Executive Officer	Apr 15 '26	Buy	2.71	11,000	29,810	1,400,372	Apr 17 07:33 AM
Qiu Wenbin	Chief Executive Officer	Apr 14 '26	Buy	2.63	11,500	30,245	1,389,372	Apr 15 06:30 AM
Qiu Wenbin	Chief Executive Officer	Apr 13 '26	Buy	2.48	12,100	30,008	1,377,872	Apr 15 06:30 AM
Wu Junhua	Chief Strategy Officer	Apr 13 '26	Buy	2.49	11,084	27,599	138,770	Apr 14 07:47 AM
Wu Junhua	Chief Strategy Officer	Apr 10 '26	Buy	2.40	5,372	12,893	127,686	Apr 14 07:47 AM
Qiu Wenbin	Chief Executive Officer	Apr 10 '26	Buy	2.43	12,400	30,132	1,365,772	Apr 13 06:19 AM
Qiu Wenbin	Chief Executive Officer	Apr 09 '26	Buy	2.58	11,650	30,057	1,353,372	Apr 13 06:19 AM
Wu Junhua	Chief Strategy Officer	Apr 08 '26	Buy	2.54	30,886	78,450	122,314	Apr 10 06:18 AM
Qiu Wenbin	Chief Executive Officer	Apr 07 '26	Buy	2.51	12,000	30,120	1,330,122	Apr 09 06:31 AM
Qiu Wenbin	Chief Executive Officer	Apr 08 '26	Buy	2.58	11,600	29,928	1,341,722	Apr 09 06:31 AM
Wu Junhua	Chief Strategy Officer	Apr 02 '26	Buy	2.47	30,000	74,019	91,428	Apr 06 08:47 AM
Wu Junhua	Chief Strategy Officer	Mar 31 '26	Buy	2.40	14,000	33,597	61,428	Apr 01 09:52 PM

INBX

Inhibrx Biosciences Inc

TDIC

Dreamland Ltd

BZUN

Baozun Inc ADR

Upgrade your Finviz experience